Fig. 4From: Two for one: targeting BCMA and CD19 in B-cell malignancies with off-the-shelf dual-CAR NK-92 cellsLysis of primary tumor samples by CAR NK-92. High cytotoxicity of CAR-engineered NK-92 towards two primary B-ALL (N = 2) and one primary MM (N = 1) tumor samples after a 4 h co-culture at different E:T ratios. ALL#, B-ALL sample number. MM#, MM sample numberBack to article page